Skip to content
In Stock Cytotec
Stomach Ulcers

Cytotec

Cytotec is intended for people receiving selected ulcer-care or specialist reproductive-health treatment. Its active ingredient, misoprostol, supports gastric mucosal defence and can stimulate…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Misoprostol
Select dosage:
Select pack Package Per unit Price
$ 5.25 $ 105.02
$ 4.57 $ 157.53 $ 137.06 Save 13%
$ 3.92 $ 315.06 $ 234.96 Save 25%
$ 3.66 $ 472.59 $ 329.30 Save 30%
Free Regular Delivery $ 3.56 $ 630.12 $ 427.20 Save 32%
Free Express Delivery $ 3.45 $ 945.18 $ 621.22 Save 34%
Free Express Delivery $ 3.38 $ 1,417.77 $ 913.14 Save 36%
Best value Free Express Delivery $ 3.12 $ 1,890.36 $ 1,121.40 Save 41%
$ 14.77 $ 147.74
$ 8.72 $ 295.48 $ 174.44 Save 41%
$ 9.67 $ 443.22 $ 290.14 Save 35%
Free Regular Delivery $ 8.69 $ 886.44 $ 521.54 Save 41%
Free Express Delivery $ 8.05 $ 1,329.66 $ 724.46 Save 46%
Free Express Delivery $ 7.22 $ 1,772.88 $ 866.86 Save 51%
Free Express Delivery $ 6.41 $ 2,659.32 $ 1,153.44 Save 57%
Free Express Delivery $ 5.24 $ 3,988.98 $ 1,415.10 Save 65%
Best value Free Express Delivery $ 4.41 $ 5,318.64 $ 1,587.76 Save 70%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Cytotec is intended for people receiving selected ulcer-care or specialist reproductive-health treatment. Its active ingredient, misoprostol, supports gastric mucosal defence and can stimulate cervical ripening and uterine contractions.

Product information

Cytotec contains misoprostol, a prostaglandin analogue that protects the gastrointestinal lining and affects the cervix and uterus. It is used in selected ulcer-care and specialist reproductive-health protocols, with the amount per intake set individually for each person.

Ingredients

Cytotec contains misoprostol, a synthetic prostaglandin analogue supplied as tablets. Prostaglandins are naturally occurring chemical messengers that influence stomach protection, smooth-muscle activity, blood flow and cervical change. Misoprostol therefore has two clinically important actions: it supports gastric mucosal defence and can stimulate cervical ripening and uterine contractions [1].

The same pharmacology that protects the stomach can affect pregnancy and the uterus. Cytotec is not suitable for self-directed pregnancy care. The correct route, amount, timing and follow-up depend on the indication, pregnancy duration, uterine history and local clinical protocol.

Misoprostol pharmacology

Misoprostol reduces gastric acid secretion and helps strengthen protective factors in the stomach and duodenum. Its effect on smooth muscle can produce abdominal cramping, diarrhoea and uterine contractions. These effects are expected parts of its pharmacology, but their clinical significance changes sharply between ulcer care and reproductive-health treatment. The response is not uniform across indications. Clinical monitoring therefore matters when uterine activity is intended.

A useful practical distinction is that tablet strength is not the same as an individual treatment dose. A clinician may prescribe a specific fraction, number or timing pattern according to the condition being treated. The amount per intake is set individually for each person rather than being one fixed number.

Do not transfer an ulcer-treatment instruction to labour induction, miscarriage management or abortion care. These indications use different clinical objectives and monitoring plans.

Clinical uses across specialties

Misoprostol may be used for selected gastrointestinal indications and in specialist reproductive-health protocols. These can include cervical ripening, induction of labour, miscarriage management and medication abortion. Protocols differ according to gestational age, route, accompanying medicines, local guidance and the availability of follow-up care.

The term abortifacient means a medicine capable of ending a pregnancy. That description concerns pharmacological action, not a recommendation for unsupervised use. Mifepristone is used with misoprostol in some medication-abortion protocols, while misoprostol alone has roles in other clinical settings.

Therapeutic indications

Misoprostol may be used for selected gastrointestinal indications and in specialist reproductive-health protocols. These can include cervical ripening, induction of labour, miscarriage management and medication abortion. Protocols differ according to gestational age, route, accompanying medicines, local guidance and the availability of follow-up care.

A duodenal ulcer is an open lesion in the lining of the first part of the small intestine. Treatment should address the underlying cause, which may include Helicobacter pylori infection, anti-inflammatory medicine exposure or excess acid-related injury.

Misoprostol can cause diarrhoea and abdominal cramping, which may limit adherence. Treatment planning therefore weighs its gastric benefit against tolerability and the availability of other evidence-based options. Reproductive-health instructions must never be copied from ulcer-treatment instructions.

Directions for use

Cytotec contains misoprostol, and the amount per intake is set individually for each person rather than being one fixed amount. It is used according to the selected ulcer-care or specialist reproductive-health protocol, which determines the frequency, timing, duration and route of administration.

When not to use it

  • Known allergy to misoprostol or another prostaglandin analogue.
  • Pregnancy when the intended treatment is not a planned, clinically supervised reproductive-health protocol.
  • Previous caesarean birth or significant uterine surgery when labour induction is being considered.
  • Suspected ectopic pregnancy.
  • Unexplained vaginal bleeding.
  • Conditions in which heavy bleeding or strong uterine contractions could create serious danger.
  • Severe dehydration or inability to maintain fluids when gastrointestinal effects are already present.

Misoprostol can interact clinically with other medicines that influence uterine activity or gastrointestinal function. The prescribing team should know about anticoagulants, medicines for inflammatory pain, ulcer treatments and all supplements. Cimetidine and other acid-reducing therapies require review of the complete treatment plan rather than automatic combination.

When this is not for you

Cytotec is not suitable for self-directed pregnancy care. A pregnancy outside the uterus, known as an ectopic pregnancy, does not respond to misoprostol and can become life-threatening without appropriate treatment.

A prior caesarean birth or other uterine surgery is a major safety factor. Scar tissue can increase the risk of uterine rupture when contractions become strong. Misoprostol may therefore be unsuitable for labour induction in people with certain uterine scars.

People with kidney or liver impairment may need closer medical review, especially when misoprostol is prescribed for gastrointestinal disease or when several medicines are used. Misoprostol can stimulate the uterus and is not used casually during an ongoing pregnancy.

Unwanted effects

Misoprostol commonly affects the gastrointestinal system because prostaglandin pathways influence smooth muscle and intestinal movement. Diarrhoea, abdominal pain or cramping, nausea, headache and dizziness can occur. The likelihood and severity depend on the indication, route, amount, pregnancy stage and individual sensitivity [2].

Common gastrointestinal and neurological effects

Possible effects include:

  • Diarrhoea.
  • Abdominal pain or cramping.
  • Nausea or vomiting.
  • Headache.
  • Dizziness.
  • Chills or temporary temperature changes.
  • Uterine cramping when used in reproductive-health care.

Diarrhoea and cramping are easy to underestimate. They can affect hydration, sleep and the ability to continue treatment for ulcer-related indications. Clinicians may change the plan if symptoms are severe or persistent.

Uterine rupture and emergency symptoms

Uterine rupture is rare but serious. The risk is influenced by uterine scars, induction circumstances, pregnancy stage and contraction intensity. Sudden severe abdominal pain, maternal collapse, heavy bleeding or an abnormal fetal heart rate require immediate emergency assessment.

An allergic reaction may cause facial or throat swelling, breathing difficulty, widespread rash or collapse. These symptoms require emergency treatment.

Mechanism of action

Misoprostol is a prostaglandin analogue that reduces gastric acid secretion, strengthens protective factors in the stomach and duodenum, and influences smooth-muscle activity. In reproductive-health care, its prostaglandin activity can stimulate cervical ripening and uterine contractions.

Common mistakes

Several mistakes can lead to poor outcomes:

  • Confusing the tablet strength with the amount prescribed for one intake.
  • Applying a labour-induction protocol to miscarriage or abortion care.
  • Using an ulcer-treatment instruction for a reproductive-health indication.
  • Failing to disclose a previous caesarean birth or uterine operation.
  • Assuming that bleeding alone confirms completion of miscarriage or abortion care.
  • Missing follow-up after medication-based treatment.
  • Ignoring severe pain, fainting, fever or heavy bleeding.
  • Taking additional medicines or supplements without disclosing them.
  • Crushing or altering tablets without a specific instruction from the prescriber.
  • Assuming that a gastrointestinal side effect is harmless when dehydration is developing.
Before treatment, write down the indication, prescribed amount, route, timing, follow-up date and emergency contact pathway. This prevents instructions from being mixed between different clinical protocols.

A prescriber or pharmacist should be told about pregnancy status, breastfeeding, prior uterine surgery, allergy history, kidney or liver disease and every medicine being taken.

Comparison

Misoprostol, oxytocin and dinoprostone all influence labour management, but they belong to different pharmacological groups. Treatment results vary with route, clinical setting, patient characteristics, cervical status and the induction protocol used. No single agent is preferred for every patient.

Active substance Main role and limitation
Misoprostol Prostaglandin analogue used for cervical change and uterine contractions; effects may continue after administration
Oxytocin Uterotonic hormone used to strengthen contractions; infusion can usually be adjusted or stopped quickly
Dinoprostone Prostaglandin E2 used for cervical ripening; uterine activity and fetal monitoring remain necessary

Uterotonic and prostaglandin differences

Oxytocin acts directly as a uterotonic, meaning it promotes uterine contractions. It is commonly given by controlled infusion in a hospital environment. Because the infusion rate can be adjusted, clinicians can respond quickly when contraction frequency or fetal monitoring changes.

Dinoprostone is prostaglandin E2. Cervidil is a dinoprostone product used in some cervical-ripening protocols. Prostaglandin effects can persist after administration, so the clinical team considers the formulation, route and ability to remove or stop exposure.

Misoprostol is chemically different from dinoprostone, even though both affect prostaglandin pathways. Comparative research cannot be transferred automatically between all hospitals or patient groups.

Cervidil and misoprostol

The choice between misoprostol and dinoprostone depends on cervical findings, uterine history, fetal status, local policy and clinician assessment. Oxytocin may be used at another stage of induction or when contractions require controlled strengthening.

The most relevant comparison is not simply which medicine is stronger. Clinicians weigh reversibility, uterine-scar risk, cervical condition, monitoring capacity and the response of the fetus.

What doctors say

Clinicians usually focus on the indication before discussing the tablet. The same active ingredient can protect the gastric lining in one setting, soften the cervix in another and stimulate uterine emptying in a third. Route, timing, pregnancy duration, uterine history and follow-up arrangements can change the risk profile substantially.

A practical clinical view is that Cytotec should be treated as a protocol-dependent medicine. It is not enough to know that a tablet contains misoprostol. The treatment plan must also identify the intended outcome, the monitoring arrangements and the point at which symptoms need urgent review.

Australian practice should be interpreted through current TGA information, relevant RANZCOG guidance, WHO recommendations and local hospital protocols. International regulatory wording differs by indication, so statements from the United States Food and Drug Administration should not be transferred automatically to Australia [3].

What customers often ask

Can Cytotec cause diarrhoea?

Yes. Misoprostol can cause diarrhoea because prostaglandin activity affects intestinal movement and fluid secretion. The 2024 TGA product information identifies gastrointestinal effects as clinically relevant, with severity varying by indication and individual response . Persistent diarrhoea, inability to drink, faintness or reduced urination needs prompt medical assessment.

Can Cytotec be combined with anti-inflammatory medicines or supplements?

The combination depends on the reason for treatment and the complete medication list. Misoprostol is sometimes used in gastrointestinal-risk settings involving anti-inflammatory medicines, but this does not make every combination suitable. Australian TGA prescribing information and a pharmacist’s medication review should guide use, especially with anticoagulants, ulcer medicines, kidney disease or supplements that affect bleeding .

Can Cytotec be used during pregnancy or breastfeeding?

Misoprostol can stimulate cervical change and uterine contractions, so pregnancy use requires a defined clinical indication and supervised protocol. It may be used in selected abortion, miscarriage or labour-care settings, while unsupervised use during an ongoing pregnancy can cause serious harm. WHO guidance published in 2022 supports indication-specific reproductive-health protocols; breastfeeding advice depends on the treatment plan and clinical circumstances [4].

Is Cytotec suitable for older adults?

Older adults may use misoprostol for selected gastrointestinal indications, but diarrhoea, dizziness and dehydration can have greater consequences. Kidney function, liver function, falls risk and concurrent medicines should be reviewed before treatment. The 2024 TGA product information remains the relevant Australian reference, and prescribers may monitor tolerability more closely in older people .

Can Cytotec tablets be split, crushed or chewed?

Do not split, crush or chew a Cytotec tablet unless the prescriber or pharmacist has given a specific instruction for that product and indication. Altering a tablet can change how the dose is delivered and can make an individually selected amount inaccurate. Product-specific administration instructions should follow the 2024 Australian TGA information and the treatment plan .

Should Cytotec be taken with food or on an empty stomach?

The timing of Cytotec in relation to food depends on the indication and the prescribed regimen. Food may influence gastrointestinal tolerability, but it does not make an unsuitable reproductive-health protocol safe. The 2024 Australian product information and the prescriber’s instructions determine the correct timing; do not change it independently when the medicine is being used for ulcer care, miscarriage management, abortion care or labour induction .

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Sources

  1. Therapeutic Goods Administration (TGA) (2024). Cytotec Product Information — misoprostol tablets.
  2. U.S. Food and Drug Administration (FDA) (2022). Cytotec (misoprostol) Prescribing Information.
  3. European Medicines Agency (EMA) (2023). Misoprostol-containing medicinal products: product information and safety information.
  4. World Health Organization (WHO) (2022). Abortion care guideline.

How Buyers Rate Cytotec

Based on 4 reviews

Natalie B., 52 Verified
Rating: 3.5 out of 5

used misoprostol for a gastrointestinal indication for several weeks: “The stomach symptoms were the reason for treatment, but diarrhoea appeared early and was inconvenient at work. The cramps settled later, although I needed the prescriber to review the plan.”

Several weeks 15 Oct 2026
Susan, 67 Verified
Rating: 4 out of 5

took Cytotec alongside anti-inflammatory treatment: “I was worried about nausea. The first few doses caused loose stools, so I became more careful about fluids and reported it rather than stopping silently. The regimen was adjusted after the review.”

24 Oct 2026
Deborah, 32 Verified
Rating: 4 out of 5

received misoprostol in a supervised reproductive-health protocol: “The cramping was stronger than I expected, and the follow-up appointment helped confirm what had happened. I would not have felt comfortable managing the process without clear emergency instructions.”

30 Oct 2026
Joanne, 48 Verified
Rating: 3.5 out of 5

experienced dizziness and abdominal pain after treatment: “The dizziness was brief, but the pain became more intense than I expected. I contacted the clinical service and was assessed rather than assuming it was a normal reaction.”

12 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 491 reviews Install